Triiodothyronine-stimulated dendritic cell vaccination boosts antitumor immunity against murine colon cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2022-08-01 / Int Immunopharmacol 2022 Sep;110:109016Avian Paramyxovirus 4 Antitumor Activity Leads to Complete Remissions and Long-term Protective Memory in Preclinical Melanoma and Colon Carcinoma Models
/in Colorectal Cancer, International Publications, Malignant Melanoma, Newcastle Disease Virus /von 2022-07-07 / Cancer Res Commun 2022 Jul;2(7):602-615Newcastle disease virus expressing an angiogenic inhibitor exerts an enhanced therapeutic efficacy in colon cancer model
/in Colorectal Cancer, International Publications, Newcastle Disease Virus /von 2022-04-05 / PLoS One 2022;17(4):e0264896Long-Term Feasibility of 13.56 MHz Modulated Electro-Hyperthermia-Based Preoperative Thermoradiochemotherapy in Locally Advanced Rectal Cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 2022-03-01 / Cancers (Basel) 2022 Mar;14(5)Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy
/in Colorectal Cancer, International Publications, Newcastle Disease Virus /von 2021-10-04 / Gene Ther 2023 Feb;30(1-2):64-74Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 2021-03-13 / Cancers (Basel) 2021 Mar;13(6)Beneficial effects of modulated electro-hyperthermia during neoadjuvant treatment for locally advanced rectal cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 2021-01-01 / Int J Hyperthermia 2021;38(1):144-151Oncolytic effects of the recombinant Newcastle disease virus, rAF-IL12, against colon cancer cells in vitro and in tumor-challenged NCr-Foxn1nu nude mice
/in Colorectal Cancer, International Publications, Newcastle Disease Virus /von 2020-12-08 / PeerJ 2020;8:e9761The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2020-08-13 / Immunotherapy 2020 Aug;
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Interview mit Prof. Dr. Volker Schirrmacher im Klassik Radio
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum